![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Deerfield Healthcare Technology Acquisitions Corporation | NASDAQ:DFHT | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.92 | 12.00 | 66.00 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): November 2, 2022
CareMax, Inc.
(Exact name of registrant as specified in its charter)
Delaware |
|
001-39391 |
|
85-0992224 |
(State or other jurisdiction |
|
(Commission File Number) |
|
(I.R.S. Employer |
|
1000 NW 57 Court, Suite 400 Miami, FL 33126 |
|
(Address of principal executive offices, including zip code) |
(786) 360-4768
(Registrant’s telephone number, including area code)
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
Name of each exchange on |
Title of each class |
|
Trading Symbols |
|
which registered |
Class A common stock, par value $0.0001 per share |
|
CMAX |
|
The Nasdaq Stock Market LLC |
Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share |
|
CMAXW |
|
The Nasdaq Stock Market LLC |
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨ |
Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Item 5.07 Submission of Matters to a Vote of Security Holders.
On November 2, 2022, CareMax, Inc., a Delaware corporation (the “Company”), held its 2022 Annual Meeting of Stockholders (the “Annual Meeting”). Of the 87,396,972 shares of Class A common stock, par value $0.0001 per share (“Common Stock”), outstanding and entitled to vote, 67,302,943 shares were represented, constituting a quorum. The final results for each of the matters submitted to a vote of the Company’s stockholders at the Annual Meeting are as follows:
Proposal 1: All of the nominees for the Company’s Board of Directors were elected to serve until the Company’s 2025 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified, by the votes set forth in the table below:
Name |
|
For |
|
Abstained |
|
Broker |
Kevin Berg |
|
64,049,566 |
|
17,643 |
|
3,235,734 |
Dr. Vincent Omachonu |
|
62,808,144 |
|
1,259,065 |
|
3,235,734 |
Ryan O'Quinn |
|
64,049,415 |
|
17,794 |
|
3,235,734 |
Proposal 2: The appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022 was ratified by the Company’s stockholders, by the votes set forth in the table below:
For |
|
Against |
|
Abstained |
|
Broker |
67,254,774 |
|
48,168 |
|
1 |
|
0 |
Proposal 3: The Company’s stockholders approved, for purposes of complying with the applicable provisions of Nasdaq Stock Market Listing Rule 5635(a), the issuance of shares of Common Stock of the Company and shares of Series A preferred stock, par value $0.0001 per share, of the Company as partial consideration for the Company’s acquisition of the Medicare Value-Based Care Business of Steward Health Care System, by the votes set forth in the table below:
For |
|
Against |
|
Abstained |
|
Broker |
64,048,971 |
|
3,533 |
|
14,705 |
|
3,235,734 |
Proposal 4: The Company’s stockholders approved the adjournment of the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if there are insufficient votes at the time of the Annual Meeting to approve Proposal 3, by the votes set forth in the table below:
For |
|
Against |
|
Abstained |
|
Broker |
62,082,052 |
|
1,970,208 |
|
14,949 |
|
3,235,734 |
Although Proposal 4 was approved, adjournment of the Annual Meeting was not necessary because the Company’s stockholders approved Proposal 3.
SIGNATURE
Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: November 3, 2022
|
CareMax, Inc. |
||
|
|
|
|
|
By: |
/s/ Kevin Wirges |
|
|
|
Name: |
Kevin Wirges |
|
|
Title: |
Executive Vice President, Chief Financial Officer and Treasurer |
1 Year Deerfield Healthcare Tec... Chart |
1 Month Deerfield Healthcare Tec... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions